B Warn the patient that GI upset nausea and vomiting are to be expected C Start

B warn the patient that gi upset nausea and vomiting

This preview shows page 21 - 34 out of 43 pages.

B. Warn the patient that GI upset, nausea, and vomiting are to be expected. C. Start taking the medicine as soon as possible to improve effectiveness of antiviral activity. D. Be sure to take most of the medication prescribed to improve effectiveness of antiviral activity.
Image of page 21
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Answer C. Start taking the medicine as soon as possible to improve effectiveness of antiviral activity. Rationale: Administer the drug as soon as possible after the diagnosis has been made to improve effectiveness of the antiviral activity.
Image of page 22
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs Used to Treat HIV/AIDS Reverse Transcriptase Inhibitors Protease Inhibitors Nucleosides Fusion Inhibitors
Image of page 23
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Reverse Transcriptase Inhibitors Action Bind directly to HIV reverse transcriptase blocking both RNA and DNA dependent DNA polymerase activities Pharmacokinetics Given orally, metabolized in the liver, excreted in the urine Contraindications Pregnancy and lactation Adverse Reactions Headache, nausea, vomiting, rash, chills, fever, diarrhea
Image of page 24
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Protease Inhibitors Action Block protease activity within the HIV virus Pharmacokinetics Contraindications Pregnancy and lactation Adverse Reactions Drug-to-Drug Interactions
Image of page 25
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Nucleosides Action Interfere with HIV replication by inhibiting cell protein synthesis Pharmacokinetics Given orally or IV; metabolized in the liver and excreted in the urine Contraindications Adverse Reactions HA, insomnia, dizziness, nausea, diarrhea, fever, rash Drug-to-Drug Interactions
Image of page 26
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Fusion Inhibitors Action Prevents the fusion of the virus with the human cellular membrane Pharmacokinetics Given sub-q; metabolized in the liver it is recycled in the tissues it is not excreted Contraindications No true contraindication Adverse Reactions HA, dizziness, myalgia, nausea, vomiting, and diarrhea Drug-to-Drug Interactions Pimozide, rifampin, triazolam, midazolam, oral contraceptive
Image of page 27
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Prototype of HIV/AIDS Antiviral Agents
Image of page 28
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Prototype of HIV/AIDS Antiviral Agents
Image of page 29
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Prototype of HIV/AIDS Antiviral Agents
Image of page 30
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Prototype of HIV/AIDS Antiviral Agents
Image of page 31
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Prototype of HIV/AIDS Antiviral Agents
Image of page 32
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Prototype of HIV/AIDS Antiviral Agents
Image of page 33
Image of page 34

You've reached the end of your free preview.

Want to read all 43 pages?

  • Summer '16
  • Antiretroviral drug, Wolters Kluwer Health, Lippincott Williams & Wilkins, Reverse transcriptase

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture